ASBMB journal events at #DiscoverBMB
The American Society for Biochemistry and Molecular Biology’s three journals — the Journal of Biological Chemistry, the Journal of Lipid Research and Molecular & Cellular Proteomics — are a big part of the society, so naturally they will be center stage at Discover BMB 2024, the ASBMB’s annual meeting, March 23-26, in San Antonio. Here are short summaries of the activities the journals’ editors have planned.
Plenary session: Metabolism and disease
Chair: Alex Toker, Beth Israel Deaconess Medical Center and Harvard Medical Schooly
The mechanisms of metabolism feature prominently in health and disease. Lydia Finley of Memorial Sloan Kettering Cancer Center will give a lecture during this plenary session examining emerging trends and insights into the metabolic pathways that make or break a cell’s success. Finley's lab researches how changes in metabolite availability shape the chromatin landscape to influence gene expression programs that control cell survival, growth and differentiation.
Journal of Biological Chemistry symposium
Chair: Philip A. Cole, Harvard University
Since 1905, the JBC has stood as a leading outlet for scientists across disciplines to share mechanistic insights on the molecular and cellular basis of biological processes. Join JBC editors for a special symposium featuring the hottest topics at the forefront of the field today at this symposium chaired by JBC Associate Editor Phil Cole of Harvard University.
- Henrik G. Dohlman, University of North Carolina at Chapel Hill
- Brian D. Strahl, University of North Carolina at Chapel Hill
- Kirill Martemyanov, The Scripps Research Institute
The power and diversity of proteomics: A symposium by Molecular & Cellular Proteomics
Chair: Al Burlingame, University of California, San Francisco
Join us for a special symposium organized by MCP Editor-in-Chief Al Burlingame of the University of California, San Francisco, on current issues in the development and applications of proteomics in basic and translational research. Explore cutting-edge techniques being used to profile bacterial proteomes, map excitable domains in neurons, understand antigen presentation and disentangle complex cell hierarchies.
- Miriam Abele, Technical University of Munich
- Matthew Rasband, Baylor College of Medicine
- Jennifer G. Abelin, Broad Institute of MIT and Harvard
- Erwin Schoof, Technical University of Denmark
Lipidomics: A symposium by the Journal of Lipid Research
Chair: Xianlin Han
JLR Associate Editor Xianlin Han of the University of Texas Health Science Center at San Antonio will chair a symposium on lipidomics as a bridge to biological and medical research. Hear from five leading experts at the forefront of genomics, proteomics and lipidomics as they relate lipid metabolism and function to insights in cardiometabolic diseases, Alzheimer’s and more.
- Peter Meikle, Baker Heart and Diabetes Institute
- Yu Xia, Tsinghua University
- David A. Ford, Saint Louis University Health Science Center
- Kim Ekroos, Lipidomics Consulting Ltd.
- Xianlin Han, University of Texas Health Science Center
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles
In memoriam: Richard Wolfenden
He was an enzymologist whose work helped spur the development of ACE inhibitor drugs and has been an ASBMB member since 1967.
Tansey named department chair
He has been a faculty member at Otterbein University since 2002.
In memoriam: Joel Habener
He discovered GLP-1, which helped pave the way for transformative diabetes and obesity therapies, and he was an ASBMB member for 25 years.
In memoriam: Walter A. Shaw
He is the namesake for the Walter A. Shaw Young Investigator Award in Lipid Research and founded Avanti Polar Lipids.
Dorn named assistant professor
She will open her lab at the University of Vermont in fall 2026, and her research will focus on catalysis, synthetic methodology and medicinal chemistry.
The data that did not fit
Brent Stockwell’s perseverance and work on the small molecule erastin led to the identification of ferroptosis, a regulated form of cell death with implications for cancer, neurodegeneration and infection.